Literature DB >> 6532176

Adjuvant polyarthritis. VIII. Differences in immunopathogenesis between type II collagen arthritis and adjuvant arthritis.

Y H Chang, Y Iizuka.   

Abstract

The severity of type II collagen-induced arthritis was found to correlate with the serum titers of anti-type II collagen antibody, but not with cell-mediated immunity to type II collagen. In contrast, no significant levels of either the humoral or the cell-mediated immunity to type II collagen were found in rats with Freund's complete adjuvant-induced arthritis. Pre-treatment of young rats with an oily preparation of type II collagen prevented the development of arthritis in these animals in response to a subsequent injection of oily preparation of type II collagen, but had no effect on the development of arthritis in response to a subsequent injection of Freund's complete adjuvant. It is concluded that while an immune response directed toward the injected type II collagen is responsible for the development of type II collagen arthritis, it does not play an important role in the induction of Freund's adjuvant-induced arthritis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6532176     DOI: 10.1007/bf01966768

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  24 in total

1.  PASSIVE TRANSFER OF ADJUVANT ARTHRITIS BY LYMPH NODE OR SPLEEN CELLS.

Authors:  C M PEARSON; F D WOOD
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

2.  PASSIVE TRANSFER OF ADJUVANT ARTHRITIS IN RATS WITH LIVING LYMPHOID CELLS OF SENSITIZED DONORS.

Authors:  B H WAKSMAN; C WENNERSTEN
Journal:  Int Arch Allergy Appl Immunol       Date:  1963

3.  Passive transfer of adjuvant-induced arthritis and allergic encephalomyelitis in rats using thoracic duct lymphocytes.

Authors:  D J Whitehouse; M W Whitehouse; C M Pearson
Journal:  Nature       Date:  1969-12-27       Impact factor: 49.962

4.  Competence of thoracic duct cells in the transfer of adjuvant disease and delayed hypersensitivity. Evidence that mycobacterial components are required for the successful transfer of the disease.

Authors:  F Quagliata; J M Phillips-Quagliata
Journal:  Cell Immunol       Date:  1972-01       Impact factor: 4.868

5.  Adjuvant polyarthritis. IV. Induction by a synthetic adjuvant: immunologic, histopathologic, and other studies.

Authors:  Y H Chang; C M Pearson; C Abe
Journal:  Arthritis Rheum       Date:  1980-01

6.  Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes. Comparison of the experimental process with human disease.

Authors:  C M PEARSON; B H WAKSMAN; J T SHARP
Journal:  J Exp Med       Date:  1961-03-01       Impact factor: 14.307

7.  Collagen-induced arthritis in rats. Evaluation of early immunologic events.

Authors:  J M Stuart; M A Cremer; A H Kang; A S Townes
Journal:  Arthritis Rheum       Date:  1979-12

8.  Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis.

Authors:  J M Stuart; M A Cremer; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

9.  Autoimmunity to type II collagen an experimental model of arthritis.

Authors:  D E Trentham; A S Townes; A H Kang
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

10.  Adjuvant polyarthritis. V. Induction by N-acetylmuramyl-L-alanyl-D-isoglutamine, the smallest peptide subunit of bacterial peptidoglycan.

Authors:  Y H Chang; C M Pearson; L Chedid
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

View more
  2 in total

Review 1.  The 65-kDa heat-shock protein in the pathogenesis, prevention and therapy of autoimmune arthritis and diabetes mellitus in rats and mice.

Authors:  U Feige; I R Cohen
Journal:  Springer Semin Immunopathol       Date:  1991

Review 2.  The role of intracellular organisms in the pathogenesis of inflammatory arthritis.

Authors:  Animesh Singh; Sarah Karrar
Journal:  Int J Inflam       Date:  2014-06-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.